LEA BUNCH: Open Payments
NPI 1114535911 · ELIZABETHTOWN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$956 in 70 payments from 11 companies in 2025. Trend: 2023 $1,306 · 2024 $1,115 · 2025 $956
Food & beverage: $956
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 23 | $200 |
| Novartis Pharmaceuticals Corporation | 14 | $189 |
| E.R. Squibb & Sons, L.L.C. | 11 | $151 |
| Merck Sharp & Dohme LLC | 6 | $94 |
| Novo Nordisk Inc | 4 | $92 |
| AstraZeneca Pharmaceuticals LP | 4 | $65 |
| Alnylam Pharmaceuticals Inc. | 3 | $60 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $41 |
| SCPHARMACEUTICALS INC. | 1 | $29 |
| HEARTFLOW, INC. | 1 | $18 |
Products named: REPATHA, LEQVIO, CAMZYOS, VERQUVO, FARXIGA, ONPATTRO, Wegovy, Kerendia.
Industry payments across KY — which companies pay providers there.
